Endovascular Today2d
CVRx Barostim Procedure Assigned CMS New Technology Outpatient Payment
CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...
Endovascular Today1d
Akura Receives IDE Approval for QUADRA-PE Pivotal Trial of Katana System
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...
Endovascular Today6d
Resource Utilization and Outcomes With Penumbra’s CAVT in Intermediate-Risk PE Patients Compared to Other Treatment Modalities
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
Endovascular Today6d
CLOUT Registry’s 2-Year Outcomes Reported for Inari’s ClotTriever to Treat DVT
Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient ...
Endovascular Today6d
Disrupt PAD BTK II Evaluates Shockwave IVL System to Treat Calcified Lesions
The Disrupt PAD BTK II study’s 30-day outcomes were revealed. The core lab–adjudicated, prospective, multicenter, s ...
Endovascular Today5d
Philips Begins Pivotal THOR Trial of Combined Device to Treat PAD
Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...
Endovascular Today5d
DEEPER OUS 2-Year Data Assess Reflow’s Spur Retrievable Spur System Combined With Paclitaxel DCB
DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...
Endovascular Today3d
LIFE-BTK Trial Implemented Several Enrollment Initiatives to Facilitate Inclusion of Diverse Populations
In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...
Endovascular Today5d
ELEGANCE Registry Studies Drug-Eluting Device Treatment of PAD in Underrepresented Minorities and Women
The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...
Endovascular Today5d
DETOUR2 Final Results Evaluate Endologix Detour for PTAB to Treat Complex Femoropopliteal Disease
The final results from the DETOUR2 study evaluated the durability of percutaneous transmural arterial bypass (PTAB) using the D ...
Endovascular Today6d
ROADSTER 3 Data Reported for Boston Scientific’s Enroute TCAR Devices
The prospective, multicenter ROADSTER 3 postapproval trial is evaluating the safety and effectiveness of transcarotid artery re ...
Endovascular Today6d
PERFORMANCE II Evaluates Contego’s Neuroguard IEP Carotid Stent System at 2 Years
The safety and effectiveness of the Neuroguard IEP (Contego Medical)—a three-in-one carotid stent system with integrated ...